View of Comparison of 1 Year Recurrent Rate in High-Risk of Recurrent Non-Muscle Invasive Bladder Cancer Who Had Received Induction Course of Intravesical BCG after TUR-BT Between Combination with Immediate Intravesical Mitomycin C and Induction Course of Intrave

Return to Article Details Comparison of 1 Year Recurrent Rate in High-Risk of Recurrent Non-Muscle Invasive Bladder Cancer Who Had Received Induction Course of Intravesical BCG after TUR-BT Between Combination with Immediate Intravesical Mitomycin C and Induction Course of Intrave Download Download PDF

นโยบายการคุ้มครองข้อมูลส่วนบุคคล Privacy policy